Jeffrey Guptill
Neurology · Durham, NCNPI 1548439383
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 77.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $42,032 and has fallen 91.5% since, to $3,578 in 2022. Among neurology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 117 payments — averaging $870.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$79K
- Regeneron$5K
- Grifols USA, LLC$5K
- UCB, Inc.$3K
- Sanofi-aventis U.S. LLC$3K
- Janssen Research & Development, LLC$2K
- plus $5K from 5 others
Across 130 payments — averaging $5489.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$282K
- Pfizer$241K
- Janssen Research & Development, LLC$64K
- UCB SA$61K
- Takeda Pharmaceuticals U.S.A., Inc.$28K
- Jacobus Pharmaceutical Company, Inc.$27K
- plus $9K from 2 others
What the payments were for
- Consulting fees$48,28947%
- Speaking & faculty fees$43,65043%
- Travel & lodging$8,8179%
- Food & beverage$1,1341%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 96 | $78,745 |
| Regeneron | 4 | $5,044 |
| Grifols USA, LLC | 8 | $4,627 |
| UCB, Inc. | 1 | $3,025 |
| Sanofi-aventis U.S. LLC | 1 | $2,948 |
| Janssen Research & Development, LLC | 1 | $2,200 |
| Janssen Global Services, LLC | 1 | $1,620 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,600 |
| BD | 2 | $945 |
| UCB SA | 1 | $825 |
| Bio Products Laboratory USA, Inc. | 1 | $313 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$101,890 in reported general payments places this provider in the 90th percentile of 566 neurology providers in North Carolina.
Other neurology in Durham
- Kevin KahnDurham$587K
- Mark SkeenDurham$562K
- Alan FinkelDurham$284K
- Natalia GonzalezDurham$220K
- Karissa GableDurham$203K
- Aatif HusainDurham$146K
- Nicole GillDurham$92K
- Rodney RadtkeDurham$69K
- Donald SandersDurham$64K
- Steve KirkDurham$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.